ari pregen

U.S. to Increase Production of Experimental Drug, but May Not Meet Demand by ANDREW POLLACK


By ANDREW POLLACK

Despite the new efforts, supplies of the drug, ZMapp, are expected to be limited to hundreds or thousands of treatment courses by early next year, which would not be nearly enough if the epidemic continues to spiral out of control.

Published: October 2, 2014 at 4:00AM

from NYT Science http://ift.tt/1rKerHg

http://aripregen.com

Standard